Managing urinary incontinence or an overactive bladder can be overwhelming, which is why many patients in Denver and Colorado Springs turn to advanced treatment options like Axonics Therapy. One of the most common questions asked is whether axonics therapy is covered by Medicare.
Medicare Coverage for Axonics Therapy
Medicare has established pathways that allow many patients access to sacral nerve stimulation therapy, including Axonics Therapy. Through national coverage determination and local coverage determination, Medicare contractors review the medical necessity of each case. This means that if conservative treatments like physical therapy or medications have not provided significant improvement, Axonics Therapy may qualify for insurance coverage. Healthcare providers at Incontinence Centers of America have years of experience helping Medicare patients navigate these requirements to ensure they understand their coverage details.
Why Axonics Therapy is a Trusted Solution
Axonics Therapy is an FDA-approved, minimally invasive outpatient procedure designed to restore normal bladder and bowel function. Using a small implantable stimulator, it delivers gentle electrical impulses to the sacral nerve, which helps improve symptoms of urinary urge incontinence, urinary retention, and bowel dysfunction. Many participants reported a significant reduction in incontinence episodes during clinical trials, showing life improvements and better quality of life for implanted patients.
For Denver and Colorado Springs patients, this means more than just symptom relief. It means access to a treatment option that can improve confidence, reduce disruptions from urinary urgency, and help restore balance in daily living.
How Medicare Patients Qualify for Coverage
Medicare coverage for sacral neuromodulation therapy, like Axonics, requires documentation of medical necessity. Most patients will need to show that more conservative treatments were tried first, such as:
- Medications for an overactive bladder
- Physical therapy or pelvic floor therapy
- Lifestyle adjustments for urinary and fecal incontinence
If these options fail to provide significant improvement, Medicare administrative contractors may approve Axonics Therapy. In many cases, Medicare Advantage plans also recognize the treatment, although coverage details can vary. Our team guides patients through each step, from reviewing medical history to coordinating with Medicare contractors for approval.
Local Expertise Near You
Patients in Denver and Colorado Springs benefit from the trusted reputation of Incontinence Centers of America. With years of experience treating urinary and fecal incontinence, our healthcare providers offer personalized care that addresses unique medical history and lifestyle needs. Whether you are managing prostate cancer recovery, multiple sclerosis, or recurrent urinary tract infections, our clinic focuses on treatment options that deliver long-term improvement in bladder and bowel function.
Benefits of Axonics Therapy
Many Medicare patients who pursue Axonics Therapy experience:
- Significant reduction in urge incontinence episodes
- Symptom relief from urinary urgency and retention
- Improvements in bowel function and bowel incontinence
- Greater quality of life with fewer daily disruptions
Because it is a minimally invasive outpatient procedure performed under local anesthesia or general anesthesia, most patients experience only mild discomfort during recovery.
About Axonics Therapy and Medicare
Does Medicare cover Axonics Therapy at Incontinence Centers of America?
What conditions can Axonics Therapy treat at Incontinence Centers of America?
This therapy supports patients dealing with urinary incontinence, fecal incontinence, urinary retention, and overactive bladder symptoms.
Is the trial period for Axonics Therapy covered by Medicare?
In many cases, the trial period is included as part of the Medicare coverage process, allowing patients to test the device before long-term implantation.
How do Medicare Advantage plans differ in coverage at Incontinence Centers of America?
Coverage details vary between Medicare Advantage plans, so our office works directly with your insurer to verify benefits and coordinate approval.
Are there risks or adverse events with Axonics Therapy?
Most patients only report mild discomfort, but as with any procedure, our providers review your medical history carefully to prevent adverse events such as lead migration.
Patient Trust and Experience
At Incontinence Centers of America, patient experiences guide our care. We have supported Medicare patients for years, helping them find treatment options that bring real relief. With proven outcomes and systematic review data showing significant improvements, we trust Axonics Therapy as one of the most effective sacral neuromodulation treatments available today.
Taking the Next Step
If you are in Denver or Colorado Springs and want to explore advanced treatment options for urinary and fecal incontinence, our clinic can help. From reviewing trial period results to discussing implantable stimulator benefits, our healthcare providers are ready to support your journey toward better bladder and bowel function. Contact Incontinence Centers of America to learn more about treatment options and how Axonics therapy can be covered by Medicare.
